Long Noncoding RNAs CAT2064 and CAT2042 May Function As Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2024 Jul 15

PMID 39005864

Authors

Farzane Amirmahani

Nasim Ebrahimi

Rafee Habib Askandar

Marzieh Rasouli Eshkaftaki

Katayoun Fazeli

Michael R Hamblin

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s12291-021-00999-6.

Citing Articles

Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance.

Elimam H, Zaki M, Abd-Elmawla M, Darwish H, Hatawsh A, Aborehab N Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39825964 DOI: 10.1007/s00210-024-03736-x.

Characterizing the Impact of Dysregulated Micrornas on CRISP3 Isoforms in Male Infertility.

Gholami D, Amirmahani F, Yazdi R, Nemati-Dehkordi M, Teimori H Reprod Sci. 2024; 31(12):3768-3778.

PMID: 39407057 DOI: 10.1007/s43032-024-01703-8.

Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs.

Hu B, Lin D, Liu Z, Chen R, Liu J, Wu Y Eur J Med Res. 2024; 29(1):411.

PMID: 39118157 PMC: 11312177. DOI: 10.1186/s40001-024-02000-5.

Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer.

Ebrahimi N, Faghihkhorasani F, Fakhr S, Moghaddam P, Yazdani E, Kheradmand Z Cell Mol Life Sci. 2022; 79(11):572.

PMID: 36308630 PMC: 11802992. DOI: 10.1007/s00018-022-04552-3.

References

Magi-Galluzzi C, Tsusuki T, Elson P, Simmerman K, LaFargue C, Esgueva R . TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate. 2010; 71(5):489-97. DOI: 10.1002/pros.21265. View

Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F . Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190(6):2278-87. DOI: 10.1016/j.juro.2013.07.001. View

Yoon J, Abdelmohsen K, Gorospe M . Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014; 34:9-14. PMC: 4163095. DOI: 10.1016/j.semcdb.2014.05.015. View

Pannek J, Partin A . Prostate-specific antigen: what's new in 1997. Oncology (Williston Park). 1997; 11(9):1273-8; discussion 1279-82. View

Adams B, Kasinski A, Slack F . Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014; 24(16):R762-76. PMC: 4177046. DOI: 10.1016/j.cub.2014.06.043. View

Gunel T, Gumusoglu E, Dogan B, Ertem F, Hosseini M, Cevik N . Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer. Arch Gynecol Obstet. 2018; 298(6):1173-1180. DOI: 10.1007/s00404-018-4913-3. View

Wu X, Xiao Y, Zhou Y, Zhou Z, Yan W . LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis. 2019; 10(7):472. PMC: 6572815. DOI: 10.1038/s41419-019-1699-6. View

Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M . Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2010; 30(16):1956-62. PMC: 3230933. DOI: 10.1038/onc.2010.568. View

Klinge C . Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. Endocr Relat Cancer. 2018; 25(4):R259-R282. DOI: 10.1530/ERC-17-0548. View

10.

Ansari M, Irani S, Edalat H, Amin R, Roushandeh A . Deregulation of miR-93 and miR-143 in human esophageal cancer. Tumour Biol. 2015; 37(3):3097-103. DOI: 10.1007/s13277-015-3987-9. View

11.

Gawronski A, Uhl M, Zhang Y, Lin Y, Niknafs Y, Ramnarine V . MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactions. Bioinformatics. 2018; 34(18):3101-3110. PMC: 6137976. DOI: 10.1093/bioinformatics/bty208. View

12.

Lorenz R, Bernhart S, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler P . ViennaRNA Package 2.0. Algorithms Mol Biol. 2011; 6:26. PMC: 3319429. DOI: 10.1186/1748-7188-6-26. View

13.

Rawla P . Epidemiology of Prostate Cancer. World J Oncol. 2019; 10(2):63-89. PMC: 6497009. DOI: 10.14740/wjon1191. View

14.

Bayat H, Narouie B, Ziaee S, Mowla S . Two long non-coding RNAs, Prcat17.3 and Prcat38, could efficiently discriminate benign prostate hyperplasia from prostate cancer. Prostate. 2018; 78(11):812-818. DOI: 10.1002/pros.23538. View

15.

Prensner J, Iyer M, Balbin O, Dhanasekaran S, Cao Q, Brenner J . Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011; 29(8):742-9. PMC: 3152676. DOI: 10.1038/nbt.1914. View

16.

Czerwinska P, Kaminska B . Regulation of breast cancer stem cell features. Contemp Oncol (Pozn). 2015; 19(1A):A7-A15. PMC: 4322524. DOI: 10.5114/wo.2014.47126. View

17.

Wang G, Zhao D, Spring D, DePinho R . Genetics and biology of prostate cancer. Genes Dev. 2018; 32(17-18):1105-1140. PMC: 6120714. DOI: 10.1101/gad.315739.118. View

18.

Hernandez R, Sanchez-Jimenez E, Melguizo C, Prados J, Rama A . Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Rep. 2018; 51(11):563-571. PMC: 6283029. View

19.

Jamalvandi M, Motovali-Bashi M, Amirmahani F, Darvishi P, Jamshidi Goharrizi K . Association of T/A polymorphism in miR-1302 binding site in CGA gene with male infertility in Isfahan population. Mol Biol Rep. 2018; 45(4):413-417. DOI: 10.1007/s11033-018-4176-x. View

20.

Fatima R, Akhade V, Pal D, Rao S . Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther. 2015; 3:5. PMC: 4469312. View